Frazier Life Sciences Management, L.P. Mirum Pharmaceuticals, Inc. Put Options Transaction History
Frazier Life Sciences Management, L.P.
- $1.9 Billion
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding MIRM
# of Institutions
184Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Bvf Inc San Francisco, CA4.37MShares$148 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$112 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$95.6 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$93.8 Million0.04% of portfolio
-
Black Rock Inc. New York, NY2.45MShares$83.1 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.25B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...